Ai companies in the uk that have raised seed funding

Fetch.ai is primarily engaged in artificial intelligence as their core business, is located in the United Kingdom, and has raised seed funding.

Humanloop is primarily engaged in artificial intelligence as their core business, is located in the United Kingdom, and has participated in Y Combinator's S20 batch, which typically involves seed funding.

Exogene matches the query because it is primarily engaged in artificial intelligence as their core business, specifically using deep learning for TCR-based cancer therapies. The company is located in the United Kingdom, as evidenced by the educational background of its employees and partnerships with UK-based institutions. Additionally, Exogene has secured funding to support TCR discovery, which implies they have raised seed funding.

Chalk is primarily engaged in artificial intelligence as their core business, is located in the United Kingdom, and has raised $10 million in seed funding.

Taktile matches the query because it is primarily engaged in artificial intelligence and machine learning as part of its core business, it has a location in London, England, United Kingdom, and it is in the early stage of development, which typically includes seed funding.

Atla is primarily engaged in artificial intelligence as their core business, is located in the United Kingdom, and has been part of the Y-Combinator batch S23, which typically involves seed funding.

bloop is primarily engaged in artificial intelligence as their core business, is located in the United Kingdom, and has participated in Y Combinator's S21 batch, which typically involves seed funding.

InstaDeep is primarily engaged in artificial intelligence as their core business, operates in the United Kingdom with a strategic office in London, and has raised seed funding as indicated by their growth and acquisition by BioNTech.

BIOS Health is primarily engaged in artificial intelligence as part of their core business, specifically in AI-driven precision medicine for the nervous system. The company is located in the United Kingdom, with locations in Cambridge, England. Additionally, BIOS Health has secured significant venture capital funding, which includes seed funding as part of their early-stage development.